(NASDAQ: BTMD) Biote's forecast annual revenue growth rate of 7.33% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.5%.
Biote's revenue in 2025 is $197,191,000.On average, 5 Wall Street analysts forecast BTMD's revenue for 2025 to be $11,237,923,443, with the lowest BTMD revenue forecast at $11,081,014,440, and the highest BTMD revenue forecast at $11,357,848,315. On average, 5 Wall Street analysts forecast BTMD's revenue for 2026 to be $12,250,938,469, with the lowest BTMD revenue forecast at $11,915,892,886, and the highest BTMD revenue forecast at $12,747,488,716.
In 2027, BTMD is forecast to generate $13,927,315,300 in revenue, with the lowest revenue forecast at $13,629,965,081 and the highest revenue forecast at $14,224,665,520.